GLI1 and lung adenocarcinoma: This is the first report to describe the clinical involvement of the GLI family of genes in advanced lung adenocarcinoma, and these results suggest that Hh signal inhibition is a good candidate therapeutic target for advanced stage lung adenocarcinoma, which provide an impetus for further investigations on the Hh signaling in NSCLC.